What is Agilent Technologies's life sciences and applied markets — net revenue?

Agilent Technologies (A) reported life sciences and applied markets — net revenue of $833.00M in Q3 2024.

How has Agilent Technologies's life sciences and applied markets — net revenue changed year-over-year?

Agilent Technologies's life sciences and applied markets — net revenue decreased by 10.2% year-over-year, from $928.00M to $833.00M.

What is the long-term trend for Agilent Technologies's life sciences and applied markets — net revenue?

Over 3 years (2021 to 2024), Agilent Technologies's life sciences and applied markets — net revenue has grown at a 4.4% compound annual growth rate (CAGR), from $2.82B to $3.22B.

What does life sciences and applied markets — net revenue mean?

The total sales revenue generated by the Life Sciences and Applied Markets business unit.

Discontinued — last reported Q3 '24

Business Segments · Net revenue

Life Sciences and Applied Markets — Net revenue

Agilent Technologies Life Sciences and Applied Markets — Net revenue increased by 6.5% to $833.00M in Q3 2024 compared to the prior quarter. Year-over-year, this metric declined by 10.2%, from $928.00M to $833.00M. Over 3 years (FY 2021 to FY 2024), Life Sciences and Applied Markets — Net revenue shows an upward trend with a 4.4% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment

CategoryGrowth

SignalHigher is better

VolatilityModerate

First reportedQ4 2013

Last reportedQ3 2024

Rolls up toTotal Revenue

How to read this metric

An increase indicates growing market share or higher demand for analytical tools, while a decrease may signal market saturation or competitive pressure.

Detailed definition

This metric represents the total gross sales generated by the Life Sciences and Applied Markets segment after accounting...

Peer comparison

Standard across life science tool providers; peers typically report this as a primary segment revenue line item.

Metric ID: a_segment_life_sciences_and_applied_markets_net_revenue

Historical Data

15 periods

	Q1 '21	Q2 '21	Q3 '21	Q4 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24
Value	$674.00M	$680.00M	$747.00M	$976.00M	$896.00M	$1.02B	$1.12B	$1.03B	$968.00M	$927.00M	$928.00M	$846.00M	$754.00M	$782.00M	$833.00M
QoQ Change	—	+0.9%	+9.9%	+30.7%	-8.2%	+13.7%	+9.5%	-7.4%	-6.3%	-4.2%	+0.1%	-8.8%	-10.9%	+3.7%	+6.5%
YoY Change	—	—	—	—	+32.9%	+49.9%	+49.4%	+5.8%	+8.0%	-9.0%	-16.8%	-18.1%	-22.1%	-15.6%	-10.2%

Range$674.00M – $1.12B

CAGR+6.2%

Avg YoY Growth+4.9%

Median YoY Growth-9.0%

Current Streak2 quarters growth

Similar Metrics at Other Companies

GLW

CorningGLW View metric

DanaherDHR View metric

GLW

CorningGLW View metric

Thermo Fisher ScientificTMO View metric

DanaherDHR View metric

Becton, Dickinson and CompanyBDX View metric

Frequently Asked Questions

What is Agilent Technologies's life sciences and applied markets — net revenue?: Agilent Technologies (A) reported life sciences and applied markets — net revenue of $833.00M in Q3 2024.
How has Agilent Technologies's life sciences and applied markets — net revenue changed year-over-year?: Agilent Technologies's life sciences and applied markets — net revenue decreased by 10.2% year-over-year, from $928.00M to $833.00M.
What is the long-term trend for Agilent Technologies's life sciences and applied markets — net revenue?: Over 3 years (2021 to 2024), Agilent Technologies's life sciences and applied markets — net revenue has grown at a 4.4% compound annual growth rate (CAGR), from $2.82B to $3.22B.
What does life sciences and applied markets — net revenue mean?: The total sales revenue generated by the Life Sciences and Applied Markets business unit.